Table 2.
ROIs |
l-THP injection dosages (mg/kg)
|
||||
---|---|---|---|---|---|
0 (n=4) | 5 (n=4) | 10 (n=4) | 20 (n=4) | 40 (n=4) | |
NAc | 0.01±0.04 | −0.01±0.05 | −0.16±0.02 | −0.31±0.07 | −0.35±0.09 |
SNR | 0.17±0.04 | −0.18±0.13 | −0.26±0.16 | −0.52±0.23 | −1.01±0.22 |
Ins | −0.06±0.08 | −0.29±0.05 | −0.54±0.11 | −0.62±0.24 | −0.82±0.26 |
HIPP | 0.02±0.02 | −0.25±0.06 | −0.42±0.22 | −0.82±0.09 | −1.20±0.24 |
IL | 0.10±0.03 | −0.03±0.03 | −0.15±0.08 | −0.35±0.07 | −1.33±0.31 |
Motor cortex | −0.02±0.02 | −0.20±0.05 | −0.32±0.13 | −0.52±0.04 | −1.20±0.18 |
Somatosensory cortex | 0.06±0.05 | −0.15±0.07 | −0.26±0.05 | −0.48±0.55 | −1.08±0.12 |
Auditory cortex | −0.00±0.13 | −0.12±0.06 | −0.31±15 | −0.29±0.04 | −1.28±0.23 |
Retrosplenium | −0.35±0.02 | −0.31±0.12 | −0.53±0.30 | −1.28±0.42 | −1.37±0.20 |
VTA | 0.37±0.12 | −0.34±0.08 | −0.63±0.12 | −0.69±0.18 | −1.58±0.29 |
Hypoth | 0.05±0.03 | −0.29±0.11 | −0.22±0.08 | −0.63±0.09 | −0.68±0.18 |
Thal | −0.04±0.02 | −0.04±0.04 | −0.38±0.05 | −0.58±0.06 | −0.94±0.15 |
Caudate putamen | −0.05±0.08 | −0.32±0.15 | −0.57±0.25 | −0.91±0.07 | −1.12±0.17 |
BNST | −0.08±0.05 | −0.22±0.30 | −0.48±0.28 | −0.61±0.14 | −0.75±0.32 |
Cl | 0.01±0.03 | −0.02±0.04 | 0.03±0.02 | −0.04±0.03 | −0.03±0.04 |
The first 14 regions (in BOLD letters), obtained from Fig. 3F, which demonstrated their dose-response activities (mean AUC%) to l-THP administration, as well as a nonresponsive region (Cl), are listed.